184
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Urinary incontinence in schizophrenic patients treated with atypical antipsychotics: urodynamic findings and therapeutic perspectives

, , , , &
Pages 116-119 | Received 14 Jul 2004, Published online: 12 Jul 2009

References

  • Bonney WW, Gupta S, Hunter DR, Arndt S. Bladder dysfunction in schizophrenia. Schizophrenia Res 1997; 25: 243–9
  • Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61(1)37–49
  • Bogerts B. The neuropathology of schizophrenic diseases: Historical aspects and present knowledge. Eur Arch Psychiatry Clin Neurosci 1999; 249(Suppl 4)2–13
  • Lin CC, Bay YM, Chen JY, Lin CY, Lan TH. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr Scand 1999; 100: 158–61
  • Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konocki PE. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry 1996; 57: 514–8
  • Vera PL, Miranda-Sousa A, Nadelhaft I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacology 2001; 1: 1–4
  • Hyman MJ, Groutz A, Blaivas JG. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol 2001; 166(2)550–2
  • Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophren Bull 1987; 13: 261–76
  • Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994; 9: 207–9
  • Murjan S, Doody G, Park B, Tavernor S, Ferguson BG. The prevalence of urinary incontinence in schizophrenia and other severe mental illness. Schizophrenia Res 2003; 60(1, Suppl. 15)46–7
  • Steers WD, Meythaler JM, Haworth C, et al. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol 1992; 148: 1849–55
  • Andersson KE. Treatment of overactive bladder: other drug mechanisms. Urology 2000; 55(Suppl 5A)51–7
  • Kreder K, Mayne C, Jonas U. Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder. Eur Urol 2002; 41: 588–95
  • Robinson D, Toosz-Hobson P. Detrusor instability. Curr Obstet Gynaecol 2000; 11: 344–52
  • Frankenburg FR, Kando JC, Centorrino F, Gilbert JM. Bladder dysfunction associated with clozapine therapy. J Clin Psychiatry 1996; 57: 39–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.